Breaking
191 Murders, 190 of Them Children: Kenya Cult Leader Paul Mackenzie Convicted✦17.8% of UC Freshmen Fail Intro Math, Double the Rate Since SAT Was Dropped✦€32 Million a Year: Spain Quadruples Union Subsidies as Membership Hits Record Low✦32% Fewer Irregular EU Crossings as Central Mediterranean Collapses✦€1.13 Million in Ministry Grants, Then the CEO Role: Germany's Revolving Door✦Italy: Boy of 13 Sets Sleeping Man Alight and Cannot Be Prosecuted✦191 Murders, 190 of Them Children: Kenya Cult Leader Paul Mackenzie Convicted✦17.8% of UC Freshmen Fail Intro Math, Double the Rate Since SAT Was Dropped✦€32 Million a Year: Spain Quadruples Union Subsidies as Membership Hits Record Low✦32% Fewer Irregular EU Crossings as Central Mediterranean Collapses✦€1.13 Million in Ministry Grants, Then the CEO Role: Germany's Revolving Door✦Italy: Boy of 13 Sets Sleeping Man Alight and Cannot Be Prosecuted✦
Wednesday, 21 October 2026Est. 2026

FRISIAN NEWS

The numbers behind the news

English · Frysk · Nederlands

The Science of Longevity Research: What We Know in 2026
World

The Science of Longevity Research: What We Know in 2026

July 29, 2026 · Frisian News

Billionaires have poured over $50 billion into longevity research, yet the only proven ways to live longer remain simple: don't smoke, exercise daily, eat real food. No new drug or gene therapy has added years to human life as of 2026.

English

Tech billionaires poured large sums into longevity research in 2025. Yet the only proven ways to live longer remain unchanged from your grandparents' era: don't smoke, exercise daily, eat real food. No new drug, supplement, or gene therapy has extended human life. The gap between investment and results grows wider each year.

The evidence base is thin. Metformin, rapamycin, and NAD+ boosters show promise in animal trials and short-term human studies. None have proven they extend human life. Some compounds reverse aging markers in cells. Reversing markers in a petri dish is not the same as reversing aging in a person. That distinction matters, but the media rarely makes it.

Who profits from longevity hype? Investors backing start-ups, executives running biotech firms, and the scientists themselves. High-profile tech investors have backed longevity start-ups. Venture capital has poured substantial funds into the sector in recent years. When every mouse study becomes a media headline, it's easy to forget that mice aren't humans.

The playbook is predictable. A study shows a compound slows aging in roundworms. Headlines scream "Breakthrough in Anti-Aging." Press releases claim a "fountain of youth." Venture firms fund a company. Human trials begin. Results disappoint. The company pivots or folds. Investors move to the next bet. Readers remember the headline, not the eventual failure.

Longevity science is real and worth funding. But if you want to live longer, start with what works. Sleep eight hours. Walk daily. Quit smoking. Eat vegetables. Pay off debt if stress shortens your life. Once you nail the basics, supplements and gene therapy might help. Until then, free advice beats expensive hype.


Published July 29, 2026 · Frisian News